World Lifestyle Archives | Page 40 of 417 | Be Korea-savvy

Archive by category World Lifestyle

Nicklaus Children’s Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

Nicklaus Children’s Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 (Korea Bizwire) Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterdam, the Netherlands, and Miami, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Nicklaus Children’s Health System, a nationally recognized leader in pediatric [...]

Shareholders Approve All Resolutions Proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

Shareholders Approve All Resolutions Proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for election confirmed Mathai Mammen, Graeme Pitkethly and Michael Rechsteiner elected as new Board members Dividend of CHF 0.45 per registered dividend-paying share approved, representing 24% of core net income Basel, April 30, 2024 – [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, April 30, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management [...]

One Za’abeel Launches The Offices, Dual Licensed Office Space in One Za’abeel Tower

One Za’abeel Launches The Offices, Dual Licensed Office Space in One Za’abeel Tower

DUBAI, United Arab Emirates, April 30, 2024 (Korea Bizwire) – One Za’abeel, the iconic mixed-use development developed by ICD (Investment Corporation of Dubai), is pleased to announce the launch of The Offices, its ultra-luxurious dual licensed corporate office spaces in One Za’abeel Tower. The Grade-A offices are set to become Dubai’s ultimate business address, attracting [...]

OKX Ventures Collaborates with Stanford’s Future of Digital Currency Initiative to Promote Blockchain Innovation and Sustainability

OKX Ventures Collaborates with Stanford’s Future of Digital Currency Initiative to Promote Blockchain Innovation and Sustainability

SINGAPORE, April 30, 2024 (Korea Bizwire) – OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today announced a research and education collaboration with Stanford’s Future of Digital Currency Initiative (FDCI), aiming to promote blockchain innovation and sustainability. As part of the Stanford School of Engineering’s Department of Computer Science, FDCI [...]

EAACI Congress 2024: Innovation and Advances in Allergy Treatment

EAACI Congress 2024: Innovation and Advances in Allergy Treatment

Over 150 scientific sessions will be presented during the congress, focusing on advancements in environmental science, food allergies, innovations in immunotherapy, and pediatric allergies, among others. Precision medicine, AI, immunotherapy, and immune modulators will converge at the largest allergy and immunology congress. The congress will occur from 31 May to 3 June in Valencia, Spain. [...]

Sandoz Reaches Agreement with Amgen Resolving All Patent Litigation Related to its US Denosumab Biosimilars

Sandoz Reaches Agreement with Amgen Resolving All Patent Litigation Related to its US Denosumab Biosimilars

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement clears path for launch of Jubbonti® and Wyost® on May 31, 2025 or earlier under certain circumstances Jubbonti® and Wyost® are first and only FDA-approved biosimilars to and interchangeable with Prolia*® and [...]

Philips Delivers First-quarter Results in Line with 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the US for USD 1.1 Billion

Philips Delivers First-quarter Results in Line with 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the US for USD 1.1 Billion

April 29, 2024 (Korea Bizwire) First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US (provision recognized of EUR 982 million) Income from operations EUR -824 million, including above provision Adjusted EBITA [...]

Less Than Half of Veterinary Professionals Feel Their Profession Is Appreciated

Less Than Half of Veterinary Professionals Feel Their Profession Is Appreciated

World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated. Veterinary associations and Boehringer Ingelheim unite to help address this issue—starting with showcasing often-unseen aspects of the veterinary profession. The World Veterinary Association’s theme for World Veterinary Day this year (April [...]

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

SHANGHAI, China, Apr. 24 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug Office, Department of Health, the Government of the Hong Kong Special Administrative Region (“DO”) has recently accepted the [...]